Growth Metrics

Sanara MedTech (SMTI) Gross Profit (2016 - 2025)

Sanara MedTech's Gross Profit history spans 15 years, with the latest figure at $25.7 million for Q4 2025.

  • For Q4 2025, Gross Profit rose 6.71% year-over-year to $25.7 million; the TTM value through Dec 2025 reached $95.6 million, up 21.76%, while the annual FY2025 figure was $95.6 million, 21.73% up from the prior year.
  • Gross Profit reached $25.7 million in Q4 2025 per SMTI's latest filing, up from $24.5 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $25.7 million in Q4 2025 to a low of $4.5 million in Q1 2021.
  • Average Gross Profit over 5 years is $14.6 million, with a median of $13.9 million recorded in 2023.
  • Peak YoY movement for Gross Profit: skyrocketed 119.24% in 2021, then grew 6.71% in 2025.
  • A 5-year view of Gross Profit shows it stood at $6.3 million in 2021, then skyrocketed by 107.13% to $12.9 million in 2022, then increased by 22.82% to $15.9 million in 2023, then skyrocketed by 51.28% to $24.1 million in 2024, then increased by 6.71% to $25.7 million in 2025.
  • Per Business Quant, the three most recent readings for SMTI's Gross Profit are $25.7 million (Q4 2025), $24.5 million (Q3 2025), and $23.9 million (Q2 2025).